Free Trial

Amprius Technologies (NYSE:AMPX) Trading 5% Higher - What's Next?

Amprius Technologies logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • AMPX jumped about 5% to $21.40 mid-day (high $21.69) on below-average volume, while Wall Street holds a consensus "Moderate Buy" (8 Buys, 1 Sell) with an average price target of $19.75, below the current share price.
  • Amprius beat the quarter with EPS of ($0.01) vs. ($0.04) expected and revenue of $25.23M, but remains unprofitable (negative net margin ~60%, negative ROE) and guides FY2026 to about -$0.06 EPS.
  • Insiders have been net sellers—2.54M shares (~$42.3M) sold in the last 90 days—while several institutional investors increased positions; insiders own ~12.8% and institutions about 5.0% of the stock.
  • Five stocks we like better than Amprius Technologies.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report)'s stock price traded up 5% during mid-day trading on Tuesday . The stock traded as high as $21.69 and last traded at $21.4030. 6,631,255 shares changed hands during trading, a decline of 23% from the average session volume of 8,611,017 shares. The stock had previously closed at $20.38.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. William Blair reaffirmed an "outperform" rating on shares of Amprius Technologies in a report on Friday, March 6th. Roth Mkm reaffirmed a "buy" rating and set a $20.00 price objective (up from $16.00) on shares of Amprius Technologies in a report on Friday, March 6th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a report on Monday, April 20th. B. Riley Financial upped their price objective on Amprius Technologies from $16.00 to $22.00 and gave the stock a "buy" rating in a report on Monday, March 9th. Finally, Cantor Fitzgerald upped their price objective on Amprius Technologies from $16.00 to $20.00 and gave the stock an "overweight" rating in a report on Friday, March 6th. Eight analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.75.

Read Our Latest Report on AMPX

Amprius Technologies Stock Performance

The firm's 50-day simple moving average is $16.95 and its 200 day simple moving average is $13.10. The company has a market cap of $2.93 billion, a P/E ratio of -62.95 and a beta of 2.20.

Amprius Technologies (NYSE:AMPX - Get Free Report) last issued its earnings results on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.03. The company had revenue of $25.23 million during the quarter, compared to analysts' expectations of $22.91 million. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. As a group, research analysts forecast that Amprius Technologies, Inc. will post -0.03 earnings per share for the current year.

Insider Buying and Selling at Amprius Technologies

In other Amprius Technologies news, Director Kang Sun sold 1,500,000 shares of the company's stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total transaction of $23,865,000.00. Following the completion of the sale, the director owned 1,342,400 shares in the company, valued at approximately $21,357,584. The trade was a 52.77% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Steven Chu sold 155,565 shares of the company's stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $18.50, for a total transaction of $2,877,952.50. Following the sale, the director owned 127,339 shares of the company's stock, valued at $2,355,771.50. The trade was a 54.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 2,539,829 shares of company stock worth $42,323,376. 12.80% of the stock is currently owned by insiders.

Institutional Trading of Amprius Technologies

Institutional investors and hedge funds have recently made changes to their positions in the business. Bank of America Corp DE increased its position in shares of Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company's stock valued at $36,000 after buying an additional 3,055 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Amprius Technologies by 86.7% in the 1st quarter. AQR Capital Management LLC now owns 77,764 shares of the company's stock valued at $208,000 after buying an additional 36,116 shares in the last quarter. Millennium Management LLC increased its position in shares of Amprius Technologies by 94.5% in the 1st quarter. Millennium Management LLC now owns 1,396,013 shares of the company's stock valued at $3,741,000 after buying an additional 678,442 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Amprius Technologies by 128.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 244,646 shares of the company's stock valued at $656,000 after buying an additional 137,640 shares in the last quarter. Finally, Rhumbline Advisers increased its position in shares of Amprius Technologies by 61.1% in the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company's stock valued at $42,000 after buying an additional 5,951 shares in the last quarter. Institutional investors own 5.04% of the company's stock.

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amprius Technologies Right Now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines